$GERN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GERON CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GERON CORP. Get notifications about new insider transactions in GERON CORP for free.
Page: < prev 1 ... 2 3 4 5 6 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 01 2009 | GERN | GERON CORP | EARP DAVID | SVP Bus Dev, Chief ... | Sell | S | 6.35 | 2,277 | 14,459 | 126,251 | 128.5 K to 126.3 K (-1.77 %) |
Jun 01 2009 | GERN | GERON CORP | GREENWOOD DAVID | EVP and CFO | Option Exercise | A | 6.52 | 40,000 | 260,800 | 1,311,341 | |
Jun 01 2009 | GERN | GERON CORP | GREENWOOD DAVID | EVP and CFO | Option Exercise | A | 6.52 | 20,000 | 130,400 | 1,271,341 | |
Jun 01 2009 | GERN | GERON CORP | GREENWOOD DAVID | EVP and CFO | Option Exercise | A | 6.52 | 35,000 | 228,200 | 1,251,341 | |
Jun 01 2009 | GERN | GERON CORP | GREENWOOD DAVID | EVP and CFO | Option Exercise | A | 6.52 | 75,000 | 489,000 | 1,216,341 | |
Jun 01 2009 | GERN | GERON CORP | GREENWOOD DAVID | EVP and CFO | Grant | A | 0.00 | 50,000 | 0 | 240,747 | 190.7 K to 240.7 K (+26.21 %) |
Jun 01 2009 | GERN | GERON CORP | GREENWOOD DAVID | EVP and CFO | Grant | A | 0.00 | 37,500 | 0 | 190,747 | 153.2 K to 190.7 K (+24.47 %) |
Jun 01 2009 | GERN | GERON CORP | GREENWOOD DAVID | EVP and CFO | Sell | S | 6.35 | 3,416 | 21,692 | 153,247 | 156.7 K to 153.2 K (-2.18 %) |
Jun 01 2009 | GERN | GERON CORP | Benedetti Fabio M | SVP, Chief Med Off, ... | Option Exercise | A | 6.52 | 35,000 | 228,200 | 185,000 | |
Jun 01 2009 | GERN | GERON CORP | Benedetti Fabio M | SVP, Chief Med Off, ... | Grant | A | 0.00 | 25,000 | 0 | 80,560 | 55.6 K to 80.6 K (+45.00 %) |
Jun 01 2009 | GERN | GERON CORP | Benedetti Fabio M | SVP, Chief Med Off, ... | Grant | A | 0.00 | 17,500 | 0 | 55,560 | 38.1 K to 55.6 K (+45.98 %) |
Jun 01 2009 | GERN | GERON CORP | Benedetti Fabio M | SVP, Chief Med Off, ... | Sell | S | 6.35 | 2,277 | 14,459 | 38,060 | 40.3 K to 38.1 K (-5.64 %) |
May 28 2009 | GERN | GERON CORP | Spink Katharine E. | VP Operations, Rege ... | Sell | S | 6.75 | 2,864 | 19,332 | 10,542 | 13.4 K to 10.5 K (-21.36 %) |
May 28 2009 | GERN | GERON CORP | OKARMA THOMAS | President and CEO | Sell | S | 6.75 | 46,669 | 315,016 | 306,433 | 353.1 K to 306.4 K (-13.22 %) |
May 28 2009 | GERN | GERON CORP | BEHRS MELISSA KELLY | SVP Oncology | Sell | S | 6.75 | 6,819 | 46,028 | 61,278 | 68.1 K to 61.3 K (-10.01 %) |
May 28 2009 | GERN | GERON CORP | LEBKOWSKI JANE | SVP, CSO Regen Med | Sell | S | 6.75 | 14,092 | 95,121 | 122,121 | 136.2 K to 122.1 K (-10.35 %) |
May 28 2009 | GERN | GERON CORP | LEBKOWSKI JANE | SVP, CSO Regen Med | Buy | I | 4.82 | 3,948 | 19,029 | 17,641 | 13.7 K to 17.6 K (+28.83 %) |
May 28 2009 | GERN | GERON CORP | HARLEY CALVIN | VP, CSO Telomerase ... | Sell | S | 6.75 | 10,001 | 67,507 | 71,313 | 81.3 K to 71.3 K (-12.30 %) |
May 28 2009 | GERN | GERON CORP | GREENWOOD DAVID | EVP and CFO | Sell | S | 6.75 | 19,320 | 130,410 | 156,663 | 176 K to 156.7 K (-10.98 %) |
May 28 2009 | GERN | GERON CORP | GREENWOOD DAVID | EVP and CFO | Buy | I | 4.82 | 3,948 | 19,029 | 7,525 | 3.6 K to 7.5 K (+110.37 %) |
May 28 2009 | GERN | GERON CORP | EARP DAVID | SVP Bus Dev, Chief ... | Sell | S | 6.75 | 15,456 | 104,328 | 128,528 | 144 K to 128.5 K (-10.73 %) |
May 28 2009 | GERN | GERON CORP | EARP DAVID | SVP Bus Dev, Chief ... | Buy | I | 4.82 | 2,985 | 14,388 | 14,765 | 11.8 K to 14.8 K (+25.34 %) |
May 20 2009 | GERN | GERON CORP | Kelsey Stephen Michael | EVP, CMO, Oncology | Option Exercise | A | 6.76 | 200,000 | 1,352,000 | 200,000 | |
Apr 06 2009 | GERN | GERON CORP | Benedetti Fabio M | SVP, Chief Med Off, ... | Sell | S | 4.44 | 5,195 | 23,066 | 40,337 | 45.5 K to 40.3 K (-11.41 %) |
Apr 06 2009 | GERN | GERON CORP | Benedetti Fabio M | SVP, Chief Med Off, ... | Buy | I | 4.82 | 2,985 | 14,388 | 2,985 | 0 to 3 K |
Feb 18 2009 | GERN | GERON CORP | ZENNER PATRICK J | Director | Option Exercise | A | 7.34 | 2,500 | 18,350 | 182,500 | |
Feb 03 2009 | GERN | GERON CORP | BEHRS MELISSA KELLY | SVP Oncology | Sell | S | 8.12 | 14,765 | 119,892 | 0 | 14.8 K to 0 (-100.00 %) |
Feb 03 2009 | GERN | GERON CORP | BEHRS MELISSA KELLY | SVP Oncology | Buy | I | 4.82 | 2,985 | 14,388 | 14,765 | 11.8 K to 14.8 K (+25.34 %) |
Jan 30 2009 | GERN | GERON CORP | WALKER JOHN PETER | Director | Option Exercise | M | 3.97 | 1,117 | 4,434 | 155,000 | |
Jan 30 2009 | GERN | GERON CORP | WALKER JOHN PETER | Director | Option Exercise | M | 3.97 | 15,000 | 59,550 | 156,117 | |
Jan 30 2009 | GERN | GERON CORP | WALKER JOHN PETER | Director | Option Exercise | M | 5.08 | 10,000 | 50,800 | 171,117 | |
Jan 30 2009 | GERN | GERON CORP | WALKER JOHN PETER | Director | Option Exercise | M | 5.08 | 2,500 | 12,700 | 181,117 | |
Jan 30 2009 | GERN | GERON CORP | WALKER JOHN PETER | Director | Option Exercise | M | 5.08 | 20,000 | 101,600 | 183,617 | |
Jan 30 2009 | GERN | GERON CORP | WALKER JOHN PETER | Director | Sell | S | 8.28 | 48,617 | 402,549 | 39,119 | 87.7 K to 39.1 K (-55.41 %) |
Jan 30 2009 | GERN | GERON CORP | WALKER JOHN PETER | Director | Buy | M | 3.97 | 1,117 | 4,434 | 87,736 | 86.6 K to 87.7 K (+1.29 %) |
Jan 30 2009 | GERN | GERON CORP | WALKER JOHN PETER | Director | Buy | M | 3.97 | 15,000 | 59,550 | 86,619 | 71.6 K to 86.6 K (+20.94 %) |
Jan 30 2009 | GERN | GERON CORP | WALKER JOHN PETER | Director | Buy | M | 5.08 | 10,000 | 50,800 | 71,619 | 61.6 K to 71.6 K (+16.23 %) |
Jan 30 2009 | GERN | GERON CORP | WALKER JOHN PETER | Director | Buy | M | 5.08 | 2,500 | 12,700 | 61,619 | 59.1 K to 61.6 K (+4.23 %) |
Jan 30 2009 | GERN | GERON CORP | WALKER JOHN PETER | Director | Buy | M | 5.08 | 20,000 | 101,600 | 59,119 | 39.1 K to 59.1 K (+51.13 %) |
Jan 30 2009 | GERN | GERON CORP | HARLEY CALVIN | VP and CSO | Sell | S | 7.08 | 25,000 | 177,000 | 99,157 | 124.2 K to 99.2 K (-20.14 %) |
Jan 30 2009 | GERN | GERON CORP | HARLEY CALVIN | VP and CSO | Sell | S | 7.14 | 5,489 | 39,191 | 124,157 | 129.6 K to 124.2 K (-4.23 %) |
Jan 30 2009 | GERN | GERON CORP | HARLEY CALVIN | VP and CSO | Buy | I | 4.82 | 3,948 | 19,029 | 129,646 | 125.7 K to 129.6 K (+3.14 %) |
Jan 06 2009 | GERN | GERON CORP | OKARMA THOMAS | President and CEO | Sell | S | 4.90 | 12,512 | 61,309 | 353,102 | 365.6 K to 353.1 K (-3.42 %) |
Jan 06 2009 | GERN | GERON CORP | LEBKOWSKI JANE | SVP Regen Medicine | Sell | S | 4.90 | 8,861 | 43,419 | 149,906 | 158.8 K to 149.9 K (-5.58 %) |
Jan 06 2009 | GERN | GERON CORP | BEHRS MELISSA KELLY | SVP Oncology | Sell | S | 4.90 | 8,861 | 43,419 | 79,877 | 88.7 K to 79.9 K (-9.99 %) |
Jan 06 2009 | GERN | GERON CORP | HARLEY CALVIN | VP and CSO | Sell | S | 4.90 | 8,861 | 43,419 | 125,698 | 134.6 K to 125.7 K (-6.59 %) |
Jan 06 2009 | GERN | GERON CORP | GREENWOOD DAVID | EVP and CFO | Sell | S | 4.90 | 10,732 | 52,587 | 179,560 | 190.3 K to 179.6 K (-5.64 %) |
Jan 06 2009 | GERN | GERON CORP | EARP DAVID | SVP Bus Dev, Chief ... | Sell | S | 4.90 | 8,861 | 43,419 | 155,764 | 164.6 K to 155.8 K (-5.38 %) |
Nov 05 2008 | GERN | GERON CORP | BEHRS MELISSA KELLY | SVP Oncology | Sell | S | 4.05 | 23,845 | 96,572 | 88,738 | 112.6 K to 88.7 K (-21.18 %) |
May 29 2008 | GERN | GERON CORP | ZENNER PATRICK J | Director | Option Exercise | A | 3.97 | 11,250 | 44,663 | 180,000 | |
May 29 2008 | GERN | GERON CORP | ZENNER PATRICK J | Director | Grant | A | 0.00 | 5,625 | 0 | 50,896 | 45.3 K to 50.9 K (+12.43 %) |
May 29 2008 | GERN | GERON CORP | WALKER JOHN PETER | Director | Option Exercise | A | 3.97 | 6,700 | 26,599 | 215,900 | |
May 29 2008 | GERN | GERON CORP | WALKER JOHN PETER | Director | Option Exercise | A | 3.97 | 15,000 | 59,550 | 209,200 | |
May 29 2008 | GERN | GERON CORP | WALKER JOHN PETER | Director | Grant | A | 0.00 | 7,500 | 0 | 59,744 | 52.2 K to 59.7 K (+14.36 %) |
May 29 2008 | GERN | GERON CORP | WALKER JOHN PETER | Director | Grant | A | 0.00 | 7,557 | 0 | 52,244 | 44.7 K to 52.2 K (+16.91 %) |
May 29 2008 | GERN | GERON CORP | KILEY THOMAS | Director | Option Exercise | A | 3.97 | 11,250 | 44,663 | 130,000 | |
May 29 2008 | GERN | GERON CORP | KILEY THOMAS | Director | Grant | A | 0.00 | 5,625 | 0 | 119,396 | 113.8 K to 119.4 K (+4.94 %) |
May 29 2008 | GERN | GERON CORP | KILEY THOMAS | Director | Grant | A | 0.00 | 5,038 | 0 | 113,771 | 108.7 K to 113.8 K (+4.63 %) |
May 29 2008 | GERN | GERON CORP | BARKAS ALEXANDER E | Director | Option Exercise | A | 3.97 | 10,000 | 39,700 | 402,500 | |
May 29 2008 | GERN | GERON CORP | BARKAS ALEXANDER E | Director | Option Exercise | A | 3.97 | 25,000 | 99,250 | 392,500 | |
May 29 2008 | GERN | GERON CORP | BARKAS ALEXANDER E | Director | Grant | A | 0.00 | 12,500 | 0 | 179,176 | 166.7 K to 179.2 K (+7.50 %) |
May 29 2008 | GERN | GERON CORP | BARKAS ALEXANDER E | Director | Grant | A | 0.00 | 10,076 | 0 | 166,676 | 156.6 K to 166.7 K (+6.43 %) |
May 29 2008 | GERN | GERON CORP | HOMCY CHARLES J | Director | Option Exercise | A | 3.97 | 10,000 | 39,700 | 85,000 | |
May 29 2008 | GERN | GERON CORP | HOMCY CHARLES J | Director | Grant | A | 0.00 | 5,000 | 0 | 37,184 | 32.2 K to 37.2 K (+15.54 %) |
May 29 2008 | GERN | GERON CORP | HOMCY CHARLES J | Director | Grant | A | 0.00 | 5,038 | 0 | 32,184 | 27.1 K to 32.2 K (+18.56 %) |
May 29 2008 | GERN | GERON CORP | FRITZKY EDWARD V | Director | Option Exercise | A | 3.97 | 10,000 | 39,700 | 223,750 | |
May 29 2008 | GERN | GERON CORP | FRITZKY EDWARD V | Director | Option Exercise | A | 3.97 | 12,500 | 49,625 | 213,750 | |
May 29 2008 | GERN | GERON CORP | FRITZKY EDWARD V | Director | Grant | A | 0.00 | 6,250 | 0 | 83,037 | 76.8 K to 83 K (+8.14 %) |
May 29 2008 | GERN | GERON CORP | FRITZKY EDWARD V | Director | Grant | A | 0.00 | 5,038 | 0 | 76,787 | 71.7 K to 76.8 K (+7.02 %) |
May 28 2008 | GERN | GERON CORP | Benedetti Fabio M | SVP, Chief Med Off, ... | Option Exercise | A | 3.97 | 50,000 | 198,500 | 150,000 | |
May 28 2008 | GERN | GERON CORP | Benedetti Fabio M | SVP, Chief Med Off, ... | Grant | A | 0.00 | 25,000 | 0 | 45,532 | 20.5 K to 45.5 K (+121.76 %) |
May 28 2008 | GERN | GERON CORP | EARP DAVID | SVP Bus Dev, Chief ... | Option Exercise | A | 3.97 | 50,000 | 198,500 | 641,250 | |
May 28 2008 | GERN | GERON CORP | EARP DAVID | SVP Bus Dev, Chief ... | Grant | A | 0.00 | 25,000 | 0 | 164,625 | 139.6 K to 164.6 K (+17.91 %) |
May 28 2008 | GERN | GERON CORP | EARP DAVID | SVP Bus Dev, Chief ... | Payment of Exercise | F | 3.92 | 15,193 | 59,557 | 139,625 | 154.8 K to 139.6 K (-9.81 %) |
May 28 2008 | GERN | GERON CORP | GREENWOOD DAVID | EVP and CFO | Option Exercise | A | 3.97 | 40,000 | 158,800 | 1,397,682 | |
May 28 2008 | GERN | GERON CORP | GREENWOOD DAVID | EVP and CFO | Option Exercise | A | 3.97 | 181,341 | 719,924 | 1,357,682 | |
May 28 2008 | GERN | GERON CORP | GREENWOOD DAVID | EVP and CFO | Option Exercise | A | 3.97 | 75,000 | 297,750 | 1,176,341 | |
May 28 2008 | GERN | GERON CORP | GREENWOOD DAVID | EVP and CFO | Grant | A | 0.00 | 37,500 | 0 | 190,292 | 152.8 K to 190.3 K (+24.54 %) |
May 28 2008 | GERN | GERON CORP | GREENWOOD DAVID | EVP and CFO | Payment of Exercise | F | 3.92 | 18,991 | 74,445 | 152,792 | 171.8 K to 152.8 K (-11.06 %) |
May 28 2008 | GERN | GERON CORP | HARLEY CALVIN | VP and CSO | Option Exercise | A | 3.97 | 134,805 | 535,176 | 794,610 | |
May 28 2008 | GERN | GERON CORP | HARLEY CALVIN | VP and CSO | Option Exercise | A | 3.97 | 50,000 | 198,500 | 659,805 | |
May 28 2008 | GERN | GERON CORP | HARLEY CALVIN | VP and CSO | Grant | A | 0.00 | 25,000 | 0 | 134,559 | 109.6 K to 134.6 K (+22.82 %) |
May 28 2008 | GERN | GERON CORP | HARLEY CALVIN | VP and CSO | Payment of Exercise | F | 3.92 | 9,830 | 38,534 | 109,559 | 119.4 K to 109.6 K (-8.23 %) |
May 28 2008 | GERN | GERON CORP | BEHRS MELISSA KELLY | SVP Oncology | Option Exercise | A | 3.97 | 14,167 | 56,243 | 420,263 | |
May 28 2008 | GERN | GERON CORP | BEHRS MELISSA KELLY | SVP Oncology | Option Exercise | A | 3.97 | 50,000 | 198,500 | 406,096 | |
May 28 2008 | GERN | GERON CORP | BEHRS MELISSA KELLY | SVP Oncology | Grant | A | 0.00 | 25,000 | 0 | 112,583 | 87.6 K to 112.6 K (+28.54 %) |
May 28 2008 | GERN | GERON CORP | BEHRS MELISSA KELLY | SVP Oncology | Payment of Exercise | F | 3.92 | 6,702 | 26,272 | 87,583 | 94.3 K to 87.6 K (-7.11 %) |
May 28 2008 | GERN | GERON CORP | LEBKOWSKI JANE | SVP Regen Medicine | Option Exercise | A | 3.97 | 10,000 | 39,700 | 667,500 | |
May 28 2008 | GERN | GERON CORP | LEBKOWSKI JANE | SVP Regen Medicine | Option Exercise | A | 3.97 | 35,000 | 138,950 | 657,500 | |
May 28 2008 | GERN | GERON CORP | LEBKOWSKI JANE | SVP Regen Medicine | Option Exercise | A | 3.97 | 50,000 | 198,500 | 622,500 | |
May 28 2008 | GERN | GERON CORP | LEBKOWSKI JANE | SVP Regen Medicine | Grant | A | 0.00 | 25,000 | 0 | 158,767 | 133.8 K to 158.8 K (+18.69 %) |
May 28 2008 | GERN | GERON CORP | LEBKOWSKI JANE | SVP Regen Medicine | Payment of Exercise | F | 3.92 | 13,852 | 54,300 | 133,767 | 147.6 K to 133.8 K (-9.38 %) |
May 28 2008 | GERN | GERON CORP | OKARMA THOMAS | President and CEO | Option Exercise | A | 3.97 | 225,000 | 893,250 | 2,135,000 | |
May 28 2008 | GERN | GERON CORP | OKARMA THOMAS | President and CEO | Option Exercise | A | 3.97 | 60,000 | 238,200 | 1,910,000 | |
May 28 2008 | GERN | GERON CORP | OKARMA THOMAS | President and CEO | Option Exercise | A | 3.97 | 100,000 | 397,000 | 1,850,000 | |
May 28 2008 | GERN | GERON CORP | OKARMA THOMAS | President and CEO | Grant | A | 0.00 | 50,000 | 0 | 365,614 | 315.6 K to 365.6 K (+15.84 %) |
May 28 2008 | GERN | GERON CORP | OKARMA THOMAS | President and CEO | Payment of Exercise | F | 3.92 | 45,878 | 179,842 | 315,614 | 361.5 K to 315.6 K (-12.69 %) |
Apr 03 2008 | GERN | GERON CORP | Benedetti Fabio M | SVP, Chief Med Off, ... | Payment of Exercise | F | 4.97 | 4,468 | 22,206 | 20,532 | 25 K to 20.5 K (-17.87 %) |
Jan 04 2008 | GERN | GERON CORP | OKARMA THOMAS | President and CEO | Sell | S | 5.34 | 13,166 | 70,306 | 361,492 | 374.7 K to 361.5 K (-3.51 %) |
Jan 04 2008 | GERN | GERON CORP | LEBKOWSKI JANE | SVP Regen Medicine | Sell | S | 5.34 | 8,911 | 47,585 | 147,619 | 156.5 K to 147.6 K (-5.69 %) |
Jan 04 2008 | GERN | GERON CORP | LEBKOWSKI JANE | SVP Regen Medicine | Buy | I | 5.73 | 3,577 | 20,496 | 13,693 | 10.1 K to 13.7 K (+35.36 %) |
Jan 04 2008 | GERN | GERON CORP | BEHRS MELISSA KELLY | SVP Oncology | Sell | S | 5.34 | 8,911 | 47,585 | 94,285 | 103.2 K to 94.3 K (-8.64 %) |
Jan 04 2008 | GERN | GERON CORP | BEHRS MELISSA KELLY | SVP Oncology | Buy | I | 5.73 | 2,705 | 15,500 | 11,780 | 9.1 K to 11.8 K (+29.81 %) |
Jan 04 2008 | GERN | GERON CORP | HARLEY CALVIN | VP and CSO | Sell | S | 5.34 | 8,911 | 47,585 | 119,389 | 128.3 K to 119.4 K (-6.95 %) |
Jan 04 2008 | GERN | GERON CORP | HARLEY CALVIN | VP and CSO | Buy | I | 5.73 | 3,577 | 20,496 | 13,895 | 10.3 K to 13.9 K (+34.67 %) |
Jan 04 2008 | GERN | GERON CORP | GREENWOOD DAVID | EVP and CFO | Sell | S | 5.34 | 11,039 | 58,948 | 171,783 | 182.8 K to 171.8 K (-6.04 %) |
Jan 04 2008 | GERN | GERON CORP | GREENWOOD DAVID | EVP and CFO | Buy | I | 5.73 | 3,577 | 20,496 | 3,577 | 0 to 3.6 K |
Jan 04 2008 | GERN | GERON CORP | Colowick Alan | President, Oncology | Buy | I | 5.73 | 2,705 | 15,500 | 3,028 | 323 to 3 K (+837.46 %) |
Jan 04 2008 | GERN | GERON CORP | EARP DAVID | SVP Bus Dev, Chief ... | Sell | S | 5.34 | 8,911 | 47,585 | 154,818 | 163.7 K to 154.8 K (-5.44 %) |
Jan 04 2008 | GERN | GERON CORP | EARP DAVID | SVP Bus Dev, Chief ... | Buy | I | 5.73 | 2,705 | 15,500 | 11,780 | 9.1 K to 11.8 K (+29.81 %) |
Nov 13 2007 | GERN | GERON CORP | GREENWOOD DAVID | EVP and CFO | Sell | S | 7.20 | 4,000 | 28,800 | 179,245 | 183.2 K to 179.2 K (-2.18 %) |
Oct 19 2007 | GERN | GERON CORP | Colowick Alan | President, Oncology | Payment of Exercise | F | 7.78 | 3,575 | 27,814 | 49,482 | 53.1 K to 49.5 K (-6.74 %) |
May 24 2007 | GERN | GERON CORP | KILEY THOMAS | Director | Option Exercise | A | 9.32 | 11,250 | 104,850 | 118,750 | |
May 24 2007 | GERN | GERON CORP | KILEY THOMAS | Director | Grant | A | 0.00 | 5,625 | 0 | 108,733 | 103.1 K to 108.7 K (+5.46 %) |
May 24 2007 | GERN | GERON CORP | KILEY THOMAS | Director | Grant | A | 0.00 | 17,500 | 0 | 103,108 | 85.6 K to 103.1 K (+20.44 %) |
May 24 2007 | GERN | GERON CORP | KILEY THOMAS | Director | Grant | A | 0.00 | 2,146 | 0 | 85,608 | 83.5 K to 85.6 K (+2.57 %) |
May 24 2007 | GERN | GERON CORP | ZENNER PATRICK J | Director | Option Exercise | A | 9.32 | 11,250 | 104,850 | 168,750 | |
May 24 2007 | GERN | GERON CORP | ZENNER PATRICK J | Director | Grant | A | 0.00 | 5,625 | 0 | 45,271 | 39.6 K to 45.3 K (+14.19 %) |
May 24 2007 | GERN | GERON CORP | ZENNER PATRICK J | Director | Grant | A | 0.00 | 17,500 | 0 | 39,646 | 22.1 K to 39.6 K (+79.02 %) |
May 24 2007 | GERN | GERON CORP | ZENNER PATRICK J | Director | Grant | A | 0.00 | 2,146 | 0 | 22,146 | 20 K to 22.1 K (+10.73 %) |
May 24 2007 | GERN | GERON CORP | WALKER JOHN PETER | Director | Option Exercise | A | 9.32 | 15,000 | 139,800 | 194,200 | |
May 24 2007 | GERN | GERON CORP | WALKER JOHN PETER | Director | Grant | A | 0.00 | 7,500 | 0 | 44,687 | 37.2 K to 44.7 K (+20.17 %) |
May 24 2007 | GERN | GERON CORP | WALKER JOHN PETER | Director | Grant | A | 0.00 | 15,000 | 0 | 37,187 | 22.2 K to 37.2 K (+67.61 %) |
May 24 2007 | GERN | GERON CORP | BARKAS ALEXANDER E | Director | Option Exercise | A | 9.32 | 25,000 | 233,000 | 367,500 | |
May 24 2007 | GERN | GERON CORP | BARKAS ALEXANDER E | Director | Option Exercise | M | 9.00 | 5,000 | 45,000 | 342,500 | |
May 24 2007 | GERN | GERON CORP | BARKAS ALEXANDER E | Director | Grant | A | 0.00 | 12,500 | 0 | 156,600 | 144.1 K to 156.6 K (+8.67 %) |
May 24 2007 | GERN | GERON CORP | BARKAS ALEXANDER E | Director | Grant | A | 0.00 | 45,000 | 0 | 144,100 | 99.1 K to 144.1 K (+45.41 %) |
May 24 2007 | GERN | GERON CORP | BARKAS ALEXANDER E | Director | Grant | A | 0.00 | 4,292 | 0 | 99,100 | 94.8 K to 99.1 K (+4.53 %) |
May 24 2007 | GERN | GERON CORP | BARKAS ALEXANDER E | Director | Buy | M | 9.00 | 5,000 | 45,000 | 94,808 | 89.8 K to 94.8 K (+5.57 %) |
May 24 2007 | GERN | GERON CORP | HOMCY CHARLES J | Director | Option Exercise | A | 9.32 | 10,000 | 93,200 | 75,000 | |
May 24 2007 | GERN | GERON CORP | HOMCY CHARLES J | Director | Grant | A | 0.00 | 5,000 | 0 | 27,146 | 22.1 K to 27.1 K (+22.58 %) |
May 24 2007 | GERN | GERON CORP | HOMCY CHARLES J | Director | Grant | A | 0.00 | 2,146 | 0 | 22,146 | 20 K to 22.1 K (+10.73 %) |
May 24 2007 | GERN | GERON CORP | FRITZKY EDWARD V | Director | Option Exercise | A | 9.32 | 11,250 | 104,850 | 201,250 | |
May 24 2007 | GERN | GERON CORP | FRITZKY EDWARD V | Director | Grant | A | 0.00 | 5,625 | 0 | 71,749 | 66.1 K to 71.7 K (+8.51 %) |
May 24 2007 | GERN | GERON CORP | FRITZKY EDWARD V | Director | Grant | A | 0.00 | 27,500 | 0 | 66,124 | 38.6 K to 66.1 K (+71.20 %) |
May 24 2007 | GERN | GERON CORP | FRITZKY EDWARD V | Director | Grant | A | 0.00 | 2,146 | 0 | 38,624 | 36.5 K to 38.6 K (+5.88 %) |
May 24 2007 | GERN | GERON CORP | OKARMA THOMAS | President and CEO | Option Exercise | A | 9.32 | 100,000 | 932,000 | 1,750,000 | |
May 24 2007 | GERN | GERON CORP | OKARMA THOMAS | President and CEO | Grant | A | 0.00 | 50,000 | 0 | 385,491 | 335.5 K to 385.5 K (+14.90 %) |
May 24 2007 | GERN | GERON CORP | OKARMA THOMAS | President and CEO | Grant | A | 0.00 | 242,500 | 0 | 335,491 | 93 K to 335.5 K (+260.78 %) |
May 24 2007 | GERN | GERON CORP | LEBKOWSKI JANE | SVP Regen Medicine | Option Exercise | A | 9.32 | 50,000 | 466,000 | 607,500 | |
May 24 2007 | GERN | GERON CORP | LEBKOWSKI JANE | SVP Regen Medicine | Grant | A | 0.00 | 25,000 | 0 | 152,953 | 128 K to 153 K (+19.54 %) |
May 24 2007 | GERN | GERON CORP | LEBKOWSKI JANE | SVP Regen Medicine | Grant | A | 0.00 | 65,000 | 0 | 127,953 | 63 K to 128 K (+103.25 %) |
May 24 2007 | GERN | GERON CORP | EARP DAVID | SVP Bus Dev, Chief ... | Option Exercise | A | 9.32 | 50,000 | 466,000 | 591,250 | |
May 24 2007 | GERN | GERON CORP | EARP DAVID | SVP Bus Dev, Chief ... | Grant | A | 0.00 | 25,000 | 0 | 161,024 | 136 K to 161 K (+18.38 %) |
May 24 2007 | GERN | GERON CORP | EARP DAVID | SVP Bus Dev, Chief ... | Grant | A | 0.00 | 72,500 | 0 | 136,024 | 63.5 K to 136 K (+114.13 %) |
May 24 2007 | GERN | GERON CORP | BEHRS MELISSA KELLY | SVP Oncology | Option Exercise | A | 9.32 | 50,000 | 466,000 | 356,096 | |
May 24 2007 | GERN | GERON CORP | BEHRS MELISSA KELLY | SVP Oncology | Grant | A | 0.00 | 25,000 | 0 | 100,491 | 75.5 K to 100.5 K (+33.12 %) |
May 24 2007 | GERN | GERON CORP | BEHRS MELISSA KELLY | SVP Oncology | Grant | A | 0.00 | 25,000 | 0 | 75,491 | 50.5 K to 75.5 K (+49.51 %) |
May 24 2007 | GERN | GERON CORP | HARLEY CALVIN | VP and CSO | Option Exercise | A | 9.32 | 50,000 | 466,000 | 609,805 | |
May 24 2007 | GERN | GERON CORP | HARLEY CALVIN | VP and CSO | Grant | A | 0.00 | 25,000 | 0 | 124,723 | 99.7 K to 124.7 K (+25.07 %) |